Biologics-based therapy for the treatment of rheumatoid arthritis.

@article{Scott2012BiologicsbasedTF,
  title={Biologics-based therapy for the treatment of rheumatoid arthritis.},
  author={David L. Scott},
  journal={Clinical pharmacology and therapeutics},
  year={2012},
  volume={91 1},
  pages={
          30-43
        }
}
  • David L. Scott
  • Published 2012
  • Medicine
  • Clinical pharmacology and therapeutics
  • Rheumatoid arthritis (RA) remains a major clinical problem, but treatments involving biologics have revolutionized its management. They target pathogenically relevant cytokines such as tumor necrosis factor and immune cells such as B cells. In RA, biologics reduce joint inflammation, limit erosive damage, decrease disability, and improve quality of life. Infections are the main risk associated with their use. Because of the high prices of biologics, their cost-effectiveness is a matter of… CONTINUE READING

    Figures and Topics from this paper.

    Paper Mentions

    OBSERVATIONAL CLINICAL TRIAL
    Aim of this project is the building-up of an integrated model of multidisciplinary research tools to support large-scale and high-quality disease-based studies.  
    ConditionsRheumatoid Arthritis
    InterventionOther

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 141 CITATIONS, ESTIMATED 57% COVERAGE

    Is there a role of synovial biopsy in drug development?

    VIEW 1 EXCERPT
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    2012
    2020

    CITATION STATISTICS

    • 10 Highly Influenced Citations

    • Averaged 13 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 105 REFERENCES

    Development of anti-TNF therapy for rheumatoid arthritis

    • M. Feldmann
    • Biology, Medicine
    • Nature Reviews Immunology
    • 2002

    Etanercept in the treatment of rheumatoid arthritis

    ▼Tocilizumab for rheumatoid arthritis